Portfolio Update

RNS Number : 1592H

Intl. Biotechnology Trust PLC

15 February 2010

 



INTERNATIONAL BIOTECHNOLOGY TRUST PLC      

Portfolio update as at 31 January 2010                                                                                  

Total Net Assets	£98.6m
NAV per share	157.6p
Share Price	126.8p
Total value of unquoted investments	£20.9m
Total number of portfolio companies	59
Cash	4%
Cash committed and reserved to unquoted investments	16%
Portfolio companies with < 1 year of cash	6%

Top Ten Holdings

Company Name	% NAV	Market Value
Micromet	9.1	8,945,986
Celgene	6.7	6,640,893
Amgen	5.9	5,811,833
Gilead Sciences	4.7	4,650,536
Genzyme	3.7	3,648,938
Alexion Pharmaceuticals	3.5	3,422,433
Wright Medical	3.0	2,947,020
Oxagen	2.9	2,909,479
EUSA Pharma	2.8	2,795,451
Insulet	2.6	2,559,073
	-----------	--------------
Total	44.9	44,331,642

Geographical Allocation	%
United States	81
Europe	13
Cash	4
Australia	2
	-----------
Total	100

Quoted/Unquoted allocation	%
Quoted	75
Unquoted	21
Cash	4
	-----------
	100

BNP Paribas Secretarial Services Limited

Company Secretary

15 FEBRUARY 2010

 

END

 

 

PFUBXGDDRGBBGGU